Premium
Management of infantile hemangiomas during the COVID pandemic
Author(s) -
Frieden Ilona J.,
Püttgen Katherine B.,
Drolet Beth A.,
Garzon Maria C.,
Chamlin Sarah L.,
Pope Elena,
Mancini Anthony J.,
Lauren Christine T.,
Mathes Erin F.,
Siegel Dawn H.,
Gupta Deepti,
Haggstrom Anita N.,
Tollefson Megha M.,
Baselga Eulalia,
Morel Kimberly D.,
Shah Sonal D.,
Holland Kristen E.,
Adams Denise M.,
Horii Kimberly A.,
Newell Brandon D.,
Powell Julie,
McCuaig Catherine C.,
Nopper Amy J.,
Metry Denise W.,
Maguiness Sheilagh
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14196
Subject(s) - medicine , telemedicine , telehealth , covid-19 , context (archaeology) , pandemic , ambulatory , intensive care medicine , clinical practice , medline , pediatrics , medical emergency , family medicine , health care , surgery , paleontology , disease , political science , infectious disease (medical specialty) , law , economics , biology , economic growth
The COVID‐19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas (IH) can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long‐term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of IH via telemedicine. FDA/EMA‐approved monitoring guidelines, clinical practice guidelines, and relevant, up‐to‐date publications regarding initiation and monitoring of beta‐blocker therapy were used to inform the recommendations. Clinical decision‐making guidelines about when telehealth is an appropriate alternative to in‐office visits, including medication initiation, dosage changes, and ongoing evaluation, are included. The importance of communication with caregivers in the context of telemedicine is discussed, and online resources for both hemangioma education and propranolol therapy are provided.